Logo

Roche Acquires Stratos Genomics to Advance the Development of Nanopore Sequencer

Share this

Roche Acquires Stratos Genomics to Advance the Development of Nanopore Sequencer

Shots:

  • Roche has acquired Stratos Genomics to facilitate the development of its nanopore sequencer to provide the healthcare community and ultimately patients with faster and cheaper clinical diagnostic testing
  • The acquisition provides Roche access to Stratos Genomics unique chemistry- Sequencing by Expansion (SBX). The addition of the SBX chemistry is expected to provide the HCPs an affordable- fast and flexible result- for multiple targeted clinical applications along with whole-exome and whole-genome sequencing
  • Stratos Genomics will continue its operations in Seattle- Washington- US. Gene sequencing technology plays a critical role in personalized healthcare and clinical diagnostics of the future

Click here ­to­ read full press release/ article 

Ref: Roche | Image: Roche 


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions